Pharma Integrity Conference 2023
Recommended for: Pharma employees who hold responsibilities associated with the generation and approval of advertising for prescription medicines in Ireland, and non-promotional interactions with stakeholders.
Essential for: Copy writers & approvers, aspiring & experienced signatories, medical affairs staff, marketers, business unit leads, patient services, compliance associates & leads, regulatory affairs, country managers / general managers.
When: Thursday 25th May; 09:00-16:30
Where: Orlagh House, Rathfarnham, Co. Dublin
Fee: €543 + VAT pp
Pharma Integrity's popular annual conference returns in 2023 to provide an opportunity to address topics of relevance and importance, and share best practice. Further details will be announced in due course.
Thursday 25th May 2023
Staying Compliant & Competitive
- The Collaborative Approach
Conference 2023 brings something for everyone, with essential key note lectures from selected industry experts with insights, tools and learns for all.
The afternoon allows for delegates to focus their attention on workstreams relevant to their operational responsibilities:
Compliance & Legal delegates will consider the compliance framework requirements relevant for their organisations.
Medical Affairs & Marketing delegates will discuss how to achieve operational success with their brands and therapy area needs.
The day concludes with a panel discussion on the future needs, opportunities and risks associated with healthcare compliance responsibilities in companies.
The event also provides ample time for networking and asking questions throughout the day.
Compliance & Legal
Setting the Bar: The Benefits of Relevant Internal Standards
– Oliver McCrohan, Daiichi Sankyo
Best Practices for Clear, Concise, and Professional Communication with the HPRA
– Olivia Murphy, AstraZeneca
Inspection Ready: Strategies for Preparing Your Organisation for a Successful Inspection
– Lucy Tobin, Pharma Integrity
Medical Affairs & Marketing
Seeing the Forest & the Trees: Key Considerations for Developing & Reviewing Materials
– Margaret Drysdale & Joanne Carroll, Takeda
Charting a Course to Market: Navigating the Post-MA / Pre-Reimbursement Space for Medicines
– Marian Hernon, AXIS Consulting
Demonstrating Standards: Options for Medical Education Accreditation
– Angela Gillian, A. Menarini